ACTRN12621000378820尚未招募未知
A cluster-randomised, parallel two-arm, controlled implementation and effectiveness trial of an adolescent digital mental health screening and treatment recommendation service for use in general practices
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 393
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Diagnosis
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 15 Years 至 o limit（—）
- 性别
- All
入选标准
- •General Practitioner eligibility criteria
- •Identified as treating young people in-person on a weekly basis, for any health condition;
- •Are using Best Practice or Medical Director Software;
- •Have WIFI available in the practice;
- •Have an overall internet speed of at least 10mbps;
- •Have HealthLink or MedicalObjects secure messaging service installed or willingness to have it installed;
- •Have the willingness to provide feedback on what type of care they recommend to youth patients with mental health problems.
- •Practice Staff eligibility criteria:
- •Practice staff (i.e. reception staff, practice nurses, practice managers) that have provided their consent will be invited to participate in the study.
- •Adolescent Patient eligibility criteria:
- •Young people presenting for an appointment to a participating GP at a participating practice will be invited to participate in the study if they are:
- •Aged 15 to 17;
- •Able to provide informed consent
- •Ability to understand English (read and spoken);
- •Have a valid email address and access to a mobile device
排除标准
- •General Practices:
- •General Practices currently using the adult StepCare digital screening service will be excluded.
- •Adolescent Patients:
- •Previously screened within the past 6 months.
- •A GP determines a patient is not well enough to participate (e.g., vomiting, weak, cognitively impaired)
研究者
相似试验
进行中（未招募）
1 期
A multi-centre, randomized, two-armed, parallel group and evaluator-blinded study of efficacy and safety of topical MOB015B in the treatment of mild to moderate distal subungual onychomycosis (DSO )Distal Subungual OnychomycosisMedDRA version: 20.0Level: PTClassification code 10030338Term: OnychomycosisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-001204-39-DEMoberg Pharma AB (publ)452
进行中（未招募）
1 期
A multi-centre, randomized, two-armed, parallel group and evaluator-blinded study of efficacy and safety of topical MOB015B in the treatment of mild to moderate distal subungual onychomycosis (DSO )EUCTR2016-001204-39-PLMoberg Pharma AB (publ)452
进行中（未招募）
1 期
A multi-centre, randomized, two-armed, parallel group and evaluator-blinded study of efficacy and safety of topical MOB015B in the treatment of mild to moderate distal subungual onychomycosis (DSO )Distal Subungual OnychomycosisMedDRA version: 20.0Level: PTClassification code 10030338Term: OnychomycosisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-001204-39-GBMoberg Pharma AB (publ)406
招募中
3 期
Comparing CinnaTropin® with Norditropin® NordiLet® in pre-pubertal children with growth hormone deficiencyHypopituitarismIRCT20150303021315N12CinnaGen company102
进行中（未招募）
不适用
An open-label, randomized, two-arm parallel group study to compare the effects of 4-week QD treatment with lixisenatide or liraglutide on the postprandial plasma glucose in patients with type 2 diabetes not adequately controlled with metformiDiabetesEUCTR2009-017666-23-DEsanofi-aventis